26m
Eli Lilly Strikes $2.9B Deal For Its 13th Acquisition This Year – As Fresh Zepbound Data Impresses
Lilly also announced that combining its inflammation treatment Taltz with Zepbound delivered lasting improvements in adults ...
The head of the world’s financial stability watchdog warned on Monday of the serious risk posed by advanced AI models to the ...
A comfortable retirement in Florida can require a nest egg of more than $1 million, depending on your household and Social ...
ServiceNow and Salesforce both posted AI-fueled earnings and both claim the future of enterprise automation, but they are ...
VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- (TSX-V: CGM, OTCQB: CGMXF) (“Canadian Goldfields” or the ...
CCL Stage 3 achieved substantial completion on August 28th, when Bechtel Energy, Inc. ("Bechtel"), Cheniere's engineering, ...
Three ad-tech names shipped agentic AI in the same stretch, and the market has judged them on separate execution records ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results